These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Some observations on SMON from Bombay. Wadia NH J Neurol Neurosurg Psychiatry; 1977 Mar; 40(3):268-75. PubMed ID: 142126 [TBL] [Abstract][Full Text] [Related]
43. [6 cases of so-called subacute myelo-optico-neuropathy with abdominal symptoms in a ward of a tuberculosis sanatorium]. Nakamura Y; Ogata J; Watanabe T; Kumagai T Shinkei Kenkyu No Shimpo; 1971; 15(4):1019-31. PubMed ID: 5168624 [No Abstract] [Full Text] [Related]
44. Subacute myelo-optic neuropathy and the halogenated hydroxyquinolines. Med J Aust; 1971 Nov; 2(21):1090-1. PubMed ID: 5127493 [No Abstract] [Full Text] [Related]
45. Experimental reproduction of SMON in animals by prolonged administration of clioquinol: clinico-pathological findings. Tateishi J; Otsuki S Jpn J Med Sci Biol; 1975; 28 Suppl():165-86. PubMed ID: 136536 [No Abstract] [Full Text] [Related]
46. [Abdominal symptoms of subacute myelo-optico-neuropathy (SMON)--with special reference to relationship between chinoform and ileus-like symptoms]. Inoue N; Tamura K; Kuroiwa Y; Ysukochi T; Naritomi T Rinsho Shinkeigaku; 1973 Sep; 13(9):537-42. PubMed ID: 4796521 [No Abstract] [Full Text] [Related]
47. [Experimental pathological study of virus isolated from the material of subacute myelo-optico-neuropathy with abdominal signs]. Nakazawa T; Tsurumizu T; Kato Y; Yoshiba K; Maruyama M Shinkei Kenkyu No Shimpo; 1970 Jul; 14(2):266-73. PubMed ID: 4989357 [No Abstract] [Full Text] [Related]
48. Outline of the joint SMON investigation by the clinical section. Kusui K Jpn J Med Sci Biol; 1975; 28 Suppl():57-62. PubMed ID: 136541 [No Abstract] [Full Text] [Related]
51. Peripheral neuropathy in rats fed with clioquinol. Jones EL; Searle CE; Smith WT J Pathol; 1972 Jul; 107(3):P8-9. PubMed ID: 4263803 [No Abstract] [Full Text] [Related]
52. [Pathohistology of the optic nerve in SMON (subacute myclo-optico neuropathy)]. Okuda K; Ueno H Nihon Ganka Kiyo; 1970 Apr; 21(4):331-40. PubMed ID: 5463341 [No Abstract] [Full Text] [Related]
53. Ethnic differences in drugs and xenobiotics. Clioquinol. Rose FC Prog Clin Biol Res; 1986; 214():323-30. PubMed ID: 2941765 [No Abstract] [Full Text] [Related]
54. Subacute myelo-optic neuropathy: a probable case in the United States. Kean BH JAMA; 1972 Apr; 220(2):243-4. PubMed ID: 4258565 [No Abstract] [Full Text] [Related]
55. Demonstration of antibody activity to clioquinol in sera of experimental rabbits and patients with subacute myelo-optico-neuropathy. Kasamaki A; Furuya K; Kanamitsu M J Toxicol Sci; 1978 May; 3(2):137-46. PubMed ID: 153407 [TBL] [Abstract][Full Text] [Related]
57. [Subacute myelo-optico-neuropathy (SMON) in Japan. The question of chinoform poisoning]. Igata A; Toyokura Y Munch Med Wochenschr; 1971 Jul; 113(31):1062-6. PubMed ID: 5109393 [No Abstract] [Full Text] [Related]
58. Identification of green pigment and analysis of clioquinol in specimens from patients with subacute myelo-optico-neuropathy. Tamura Z; Yoshioka M; Imanari T; Fukaya J; Kusaka J Clin Chim Acta; 1973 Aug; 47(1):13-20. PubMed ID: 4270607 [No Abstract] [Full Text] [Related]
59. Clioquinol: To harm or heal. Perez DR; Sklar LA; Chigaev A Pharmacol Ther; 2019 Jul; 199():155-163. PubMed ID: 30898518 [TBL] [Abstract][Full Text] [Related]